Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:25 pm Purchase | 2024-09-30 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 3,445,363 7.220% | 751,782 (+27.91%) | Filing History |
| 2024-11-12 11:44 am Purchase | 2024-09-30 | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 3,406,072 7.100% | 37,915 (+1.13%) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 3,368,157 7.100% | 835,515 (+32.99%) | Filing History |
| 2024-07-10 1:12 pm Purchase | 2024-06-28 | 13G | MIRUM PHARMACEUTICALS INC MIRM | JANUS HENDERSON GROUP PLC JHG | 4,988,747 10.600% | 4,988,747 (New Position) | Filing History |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 2,693,581 5.780% | 636,581 (+30.95%) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | MIRUM PHARMACEUTICALS INC MIRM | The Vanguard Group | 2,476,244 5.310% | 2,476,244 (New Position) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 2,532,642 5.400% | 854,735 (+50.94%) | Filing History |
| 2023-12-29 4:01 pm Sale | 2023-12-21 | 13D | MIRUM PHARMACEUTICALS INC MIRM | New Enterprise Associates 16, L.P. | 0 0.000% | -2,186,243 (Position Closed) | Filing History |
| 2023-09-18 4:35 pm Purchase | 2023-09-07 | 13G | MIRUM PHARMACEUTICALS INC MIRM | BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% | 4,370,024 (New Position) | Filing History |
| 2023-09-05 3:11 pm Purchase | 2023-08-31 | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX, L.P. | 6,226,392 13.400% | 1,815,285 (+41.15%) | Filing History |
| 2023-06-23 2:32 pm Sale | 2023-06-13 | 13D | MIRUM PHARMACEUTICALS INC MIRM | New Enterprise Associates 16, L.P. | 2,186,243 5.800% | -2,000,000 (-47.78%) | Filing History |
| 2023-05-03 4:58 pm Sale | 2023-05-03 | 13G | MIRUM PHARMACEUTICALS INC MIRM | James E. Flynn | 0 0.000% | -2,032,335 (Position Closed) | Filing History |
| 2023-04-14 12:45 pm Purchase | 2023-04-12 | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX, L.P. | 4,411,107 11.600% | 549,326 (+14.22%) | Filing History |
| 2023-03-08 2:15 pm Sale | 2023-02-28 | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 1,677,907 4.600% | -458,770 (-21.47%) | Filing History |
| 2023-02-14 3:00 pm Purchase | 2022-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,795,733 4.870% | 256,919 (+16.70%) | Filing History |
| 2023-02-14 1:34 pm Purchase | 2022-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Eventide Asset Management, LLC | 2,057,000 5.600% | 2,057,000 (New Position) | Filing History |
| 2023-02-10 09:34 am Unchanged | 2022-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | James E. Flynn | 2,032,335 5.510% | 0 (Unchanged) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | BlackRock Inc. BLK | 2,136,677 5.800% | 2,136,677 (New Position) | Filing History |
| 2022-12-01 11:07 am Sale | 2022-11-11 | 13D | MIRUM PHARMACEUTICALS INC MIRM | RiverVest Venture Fund IV L.P. | 1,621,118 4.400% | -300,000 (-15.62%) | Filing History |
| 2022-09-12 5:23 pm Sale | 2022-09-08 | 13G | MIRUM PHARMACEUTICALS INC MIRM | James E. Flynn | 2,032,335 5.530% | -1,250,577 (-38.09%) | Filing History |